Limited reimbursement amounts may reduce the demand for, or the price of, Elfabrio, Elelyso or any other future products. If coverage and reimbursement are not available or are 39 available only to limited levels, the sales of Elfabrio, Elelyso or other future products, if any, may be diminished or we may not be able to sell such products profitably.
All entries for: Protalix Biotherapeutics
May 8, 2025
Protalix Biotherapeutics
Negative Outlook
Hackensack, Nj
201-500 employees
Disease Area: Rare Diseases
Drug Type: Biologic